Skip to main content

. 1977;70(Suppl 2):7–15. doi: 10.1177/00359157770700S203

The pharmacological basis of the clinical use of dopamine.

PMCID: PMC1543333 PMID: 264204

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Crumly H. J., Jr, Pinder R. M., Hinshaw W. B., Goldberg L. I. Dopamine-like renal and mesenteric vasodilation caused by apomorphine 6-propylnorapomorphine and 2-amino-6, 7-dihydroxy-1,2,3,4-tetrahydronaphthalene. Nature. 1976 Feb 19;259(5544):584–587. doi: 10.1038/259584a0. [DOI] [PubMed] [Google Scholar]
EBLE J. N. A PROPOSED MECHANISM FOR THE DEPRESSOR EFFECT OF DOPAMINE IN THE ANESTHETIZED DOG. J Pharmacol Exp Ther. 1964 Jul;145:64–70. [PubMed] [Google Scholar]
GOLDBERG L. I., MCDONALD R. H., Jr, ZIMMERMAN A. M. SODIUM DIURESIS PRODUCED BY DOPAMINE IN PATIENTS WITH CONGESTIVE HEART FAILURE. N Engl J Med. 1963 Nov 14;269:1060–1064. doi: 10.1056/NEJM196311142692003. [DOI] [PubMed] [Google Scholar]
Goldberg L. I., Sonneville P. F., McNay J. L. An investigation of the structural requirements for dopamine-like renal vasodilation: phenylethylamines and apomorphine. J Pharmacol Exp Ther. 1968 Sep;163(1):188–197. [PubMed] [Google Scholar]
Goldberg L. I. Use of sympathomimetic amines in heart failure. Am J Cardiol. 1968 Aug;22(2):177–182. doi: 10.1016/0002-9149(68)90223-3. [DOI] [PubMed] [Google Scholar]
Goldberg L. I., Yeh B. K. Attenuation of dopamine-induced renal vasodilation in the dog by phenothiazines. Eur J Pharmacol. 1971 Jun;15(1):36–40. doi: 10.1016/0014-2999(71)90075-6. [DOI] [PubMed] [Google Scholar]
HORWITZ D., FOX SM 3. D., GOLDBERG L. I. Effects of Dopamine in man. Circ Res. 1962 Feb;10:237–243. doi: 10.1161/01.res.10.2.237. [DOI] [PubMed] [Google Scholar]
Iversen L. L. Dopamine receptors in the brain. Science. 1975 Jun 13;188(4193):1084–1089. doi: 10.1126/science.2976. [DOI] [PubMed] [Google Scholar]
MCDONALD R. H., Jr, GOLDBERG L. I., MCNAY J. L., TUTTLE E. P., Jr EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW. J Clin Invest. 1964 Jun;43:1116–1124. doi: 10.1172/JCI104996. [DOI] [PMC free article] [PubMed] [Google Scholar]
MacCannell K. L., McNay J. L., Meyer M. B., Goldberg L. I. Dopamine in the treatment of hypotension and shock. N Engl J Med. 1966 Dec 22;275(25):1389–1398. doi: 10.1056/NEJM196612222752501. [DOI] [PubMed] [Google Scholar]
McNay J. L., Goldberg L. I. Comparison of the effects of dopamine, isoproterenol, norepinephrine and bradykinin on canine renal and femoral blood flow. J Pharmacol Exp Ther. 1966 Jan;151(1):23–31. [PubMed] [Google Scholar]
Orme M. L., Breckenridge A., Dollery C. T. The effects of long term administration of dopamine on renal function in hypertensive patients. Eur J Clin Pharmacol. 1973 Oct;6(3):150–155. doi: 10.1007/BF00558278. [DOI] [PubMed] [Google Scholar]
Toda N., Goldberg L. I. Effects of dopamine on isolated canine coronary arteries. Cardiovasc Res. 1975 May;9(3):384–389. doi: 10.1093/cvr/9.3.384. [DOI] [PubMed] [Google Scholar]
Yeh B. K., McNay J. L., Goldberg L. I. Attenuation of dopamine renal and mesenteric vasodilation by haloperidol: evidence for a specific dopamine receptor. J Pharmacol Exp Ther. 1969 Aug;168(2):303–309. [PubMed] [Google Scholar]
von Essen C. Effects of dopamine, noradrenaline and 5-hydroxytryptamine on the cerebral blood flow in the dog. J Pharm Pharmacol. 1972 Aug;24(8):668–668. doi: 10.1111/j.2042-7158.1972.tb09086.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES